Bronchiectasis News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Investigational Imaging Technology Allows Deep Look at Lungs, Quickly Detecting Bacteria - Bronchiectasis News Today



Bronchiectasis News Today
 
Investigational Imaging Technology Allows Deep Look at Lungs, Quickly Detecting Bacteria 
Bronchiectasis News Today
New medical imaging technology being developed by British researchers allows doctors to see bacteria deep inside patients' lungs ? an unprecedented achievement that may enable detection of harmful bacteria in less than 60 seconds. Bronchiectasis is ...

 


Stem Cell Transplants Rejuvenate Chinese Bronchiectasis Patients' Damaged Lungs - Bronchiectasis News Today



Bronchiectasis News Today
 
Stem Cell Transplants Rejuvenate Chinese Bronchiectasis Patients' Damaged Lungs 
Bronchiectasis News Today
The team isolated lung stem cells from two bronchiectasis patients, expanded them, then delivered them to the patients' lungs with a tube known as a bronchoscope that has a tiny camera on the end. Within three months of the transplants, the patients ...

 


Bronchiectasis Treatment Market Growth, Size Estimation and ... - The Financial



Bronchiectasis Treatment Market Growth, Size Estimation and ... 
The Financial
Bronchiectasis Treatment Market Research Report has the complete assessment of the latest trends of the Bronchiectasis Treatment market. The report focuses on the manufacturing challenges that are being faced and provides the solutions and the ...

and more » 


Electromed: At 12x EV/EBIT, This Double-Digit Grower Is A Bargain - Seeking Alpha



Electromed: At 12x EV/EBIT, This Double-Digit Grower Is A Bargain 
Seeking Alpha
The company should post low- to high-teens long-term growth on the back of its expansion into the underpenetrated bronchiectasis market. The stock currently offers a very attractive risk/award opportunity with 50+% upside potential over the next 12-24 ...

 


S. aureus Infection Not Strongly Linked to Decline in Bronchiectasis Patients, Study Reports - Bronchiectasis News Today



Bronchiectasis News Today
 
S. aureus Infection Not Strongly Linked to Decline in Bronchiectasis Patients, Study Reports 
Bronchiectasis News Today
An airway infection caused by Staphylococcus aureus is not an independent risk factor for more severe disease in bronchiectasis patients, a study published in the Annals of the American Thoracic Society reports. People with bronchiectasis are prone to ...

 


Aradigm's Linhaliq NDA for Non-CF Bronchiectasis Fails to Get FDA Approval - Bronchiectasis News Today



Bronchiectasis News Today
 
Aradigm's Linhaliq NDA for Non-CF Bronchiectasis Fails to Get FDA Approval 
Bronchiectasis News Today
The U.S. Food and Drug Administration (FDA) told Aradigm the agency could not approve the company's New Drug Application (NDA) for Linhaliq in its present form. Linhaliq is designed to treat patients with non-cystic fibrosis bronchiectasis who get ...
The Klein Law Firm Notifies Aradigm Corporation Shareholders of a Class Action and a Lead Plaintiff Deadline of ... Business Wire (press release)
Another FDA blow for Aradigm sees shares slump nearly 40% The Pharma Letter

all 34 news articles » 


Bronchiectasis Market Pipeline Therapeutics, Products ... - The Financial



Bronchiectasis Market Pipeline Therapeutics, Products ... 
The Financial
Bronchiectasis Market Pipeline therapeutics 2018 presents an in-depth assessment of the pipeline (under development) therapeutics scenario and growth prospects across Bronchiectasis Market development. The report additionally provides detailed coverage ...

and more » 


FDA Gives Aradigm Recommendations for Resubmitting Bronchiectasis Therapy Application - Lung Disease News



Lung Disease News
 
FDA Gives Aradigm Recommendations for Resubmitting Bronchiectasis Therapy Application 
Lung Disease News
The U.S. Food and Drug Administration has given Aradigm a list of suggestions for resubmitting an application for regulatory review of its bronchiectasis therapy Linhaliq. A review board had recommended against the FDA accepting Aradigm's New Drug ...
US FDA serves Aradigm CRL, Phase III data wanted In-PharmaTechnologist.com

all 2 news articles » 


Bronchiectasis Pipeline Research Report 2018 - Version of Event



Version of Event
 
Bronchiectasis Pipeline Research Report 2018 
Version of Event
Bronchiectasis- Competitive Landscape, Pipeline and Market Analysis, 2017, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of action. Key objective of the report is to establish the understanding for all ...

and more » 


Researchers report first lung stem cell transplantation clinical trial - Medical Xpress



Medical Xpress
 
Researchers report first lung stem cell transplantation clinical trial 
Medical Xpress
Also, the fibrotic area in the injured lungs of the mice was replaced by new human alveoli after receiving stem cell transplantation. Arterial blood gas analysis showed that the lung function of the mice was significantly recovered. Together with ...

and more »